脳深部刺激装置の市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別、地域別- 産業予測、2025-2032年

脳深部刺激（DBS）装置の世界市場規模は、2023年に15億4,000万米ドルと評価され、2024年の16億8,000万米ドルから2032年には34億米ドルに成長し、予測期間（2025-2032年）のCAGRは9.2％で成長する見通しです。

世界の脳深部刺激療法装置市場は、パーキンソン病や本態性振戦などの神経疾患の罹患率が上昇し、効果的な治療ソリューションに対する需要が高まっていることを背景に、堅調な成長を遂げています。長寿命の充電式装置やターゲティングシステムの改良など、DBS技術の進歩により、手技の有効性と安全性が向上しています。DBSが信頼できる治療法として受け入れられ、患者や医療従事者の意識が高まっていることも、市場拡大に大きく寄与しています。先進地域における好意的な償還政策と新興国市場におけるヘルスケア投資の拡大が、メーカーにとっての成長機会をさらに後押ししています。全体として、これらの要因が収束することで、DBS装置市場は今後数年間で大きく前進するものと思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析
• 規制分析

脳深部刺激装置市場規模：製品タイプ別

• 市場概要
• シングルチャネルDBSデバイス
• デュアルチャネルDBSデバイス

脳深部刺激装置市場規模：用途別

• 市場概要
• てんかん
• 疼痛管理
• 本態性振戦
• 強迫性障害（OCD）
• パーキンソン病
• うつ
• ジストニア
• その他

脳深部刺激装置市場規模：エンドユーザー別

• 市場概要
• 病院
• 神経科クリニック
• 外来手術センター
• 研究センター
• その他

脳深部刺激装置市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic Plc.（USA）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Aleva Neurotherapeutics S.A.（Switzerland）
• Beijing PINS Medical Co., Ltd.（China）
• Brainsway Ltd.（USA）
• NeuroPace Inc.（USA）
• Functional Neuromodulation Ltd.（USA）
• NeuroSigma, Inc.（USA）
• Beijing Pinchi Medical Equipment Co., Ltd.（China）
• SceneRay Corporation Ltd.（China）
• Sapiens Steering Brain Stimulation（Netherlands）
• Renishaw plc（UK）
• Synapse Biomedical Inc.（USA）
• Deep Brain Innovations LLC（USA）
• Newronika S.p.A.（Italy）
• Nexstim Plc（Finland）
• Neuronetics, Inc.（USA）
• Magstim Company Limited（UK）
• Bioinduction Ltd.（UK）

結論と提言

Global Deep Brain Stimulation Devices Market size was valued at USD 1.54 billion in 2023 and is poised to grow from USD 1.68 billion in 2024 to USD 3.4 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

The global deep brain stimulation (DBS) device market is experiencing robust growth, driven by the rising incidence of neurological disorders such as Parkinson's disease and essential tremor, which has intensified the demand for effective treatment solutions. Advances in DBS technology, including longer-lasting rechargeable devices and improved targeting systems, have enhanced procedural efficacy and safety. Increased acceptance of DBS as a credible treatment, along with heightened awareness among patients and healthcare professionals, contributes significantly to market expansion. Favorable reimbursement policies in developed regions and escalating healthcare investments in emerging markets are further propelling growth opportunities for manufacturers. Overall, the convergence of these factors positions the DBS device market for substantial advancement in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Deep Brain Stimulation Devices Market Segments Analysis

Global Deep Brain Stimulation Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Single-channel DBS Devices and Dual-channel DBS Devices. Based on Application, the market is segmented into Epilepsy, Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinson's Disease, Depression, Dystonia and Others. Based on End User, the market is segmented into Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation Devices market is primarily driven by innovations in technology that have markedly enhanced patient outcomes and broadened the array of conditions that can be effectively treated. Key advancements include the creation of highly accurate targeting systems and refined stimulation parameters, alongside the incorporation of sophisticated features like closed-loop systems and adaptive algorithms. These technological improvements facilitate personalized treatment regimens, optimize symptom management, and lessen potential side effects, thereby strengthening the overall efficacy and safety of deep brain stimulation therapy. As a result, the market is experiencing robust growth fueled by these transformative developments.

Restraints in the Global Deep Brain Stimulation Devices Market

The global deep brain stimulation devices market faces significant restraints primarily due to the complexity of these devices, which necessitate precise implantation surgeries conducted by highly skilled neurosurgeons. The overall expenses associated with these devices-encompassing the hardware, leads, and programming systems-can be quite high. Furthermore, the costs associated with the surgical procedure increase as they require specialized equipment, operating room facilities, and extensive post-operative care. This high financial burden presents a barrier to affordability and accessibility, particularly in regions where healthcare resources are scarce or insurance coverage is insufficient, limiting the market's potential growth.

Market Trends of the Global Deep Brain Stimulation Devices Market

The Global Deep Brain Stimulation (DBS) Devices market is witnessing significant growth, largely fueled by the rising prevalence of neurological disorders, particularly among the aging population. Conditions such as Parkinson's disease, essential tremor, and dystonia are becoming increasingly common due to factors like chronic disease proliferation and exposure to environmental toxins. As awareness about DBS as a highly effective treatment option spreads, there is a marked increase in demand for these devices. This trend underscores a shifting focus towards innovative surgical interventions in neurology, positioning the DBS market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis

Global Deep Brain Stimulation Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Single-channel DBS Devices
• Dual-channel DBS Devices

Global Deep Brain Stimulation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Epilepsy
• Pain Management
• Essential Tremor
• Obsessive Compulsive Disorder (OCD)
• Parkinson's Disease
• Depression
• Dystonia
• Others

Global Deep Brain Stimulation Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers
• Research Centers
• Others

Global Deep Brain Stimulation Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic Plc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brainsway Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Functional Neuromodulation Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing Pinchi Medical Equipment Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SceneRay Corporation Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sapiens Steering Brain Stimulation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renishaw plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deep Brain Innovations LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Newronika S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magstim Company Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinduction Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations